Afsaneh Gray is a freelance science journalist based in London
A new class of sleep medicines, could provide relief for people living with insomnia, but pharmaceutical companies are struggling to bring them to the market.
Health anxiety: currently trendingSubscription
Do pharmacists have a role in reducing the side effects of ‘Dr Google’?
It’s been a long time coming, but a new class of drugs targeting the CGRP protein could be the first preventative treatment specifically developed for migraine to hit the market.
Multiple myeloma: an expensive revolutionSubscription